OBJECTIVES: To identify, characterize and compare the frequency of mild cognitive impairment (MCI) subtypes at baseline in a large, late-life cohort (n = 3063) recruited into a dementia prevention trial. METHOD: A retrospective, data-algorithmic approach was used to classify participants as cognitively normal or MCI with corresponding subtype (e.g. amnestic vs. non-amnestic, single domain vs. multiple domain) based on a comprehensive battery of neuropsychological test scores, with and without Clinical Dementia Rating (CDR) global score included in the algorithm. RESULTS: Overall, 15.7% of cases (n = 480) were classified as MCI. Amnestic MCI was characterized as unilateral memory impairment (i.e. only verbal or only visual memory impaired) or bilateral memory impairment (i.e. both verbal and visual memory impaired). All forms of amnestic MCI were almost twice as frequent as non-amnestic MCI (10.0% vs. 5.7%). Removing the CDR = 0.5 ('questionable dementia') criterion resulted in a near doubling of the overall MCI frequency to 28.1%. CONCLUSION: Combining CDR and cognitive test data to classify participants as MCI resulted in overall MCI and amnestic MCI frequencies consistent with other large community-based studies, most of which relied on the 'gold standard' of individual case review and diagnostic consensus. The present data-driven approach may prove to be an effective alternative for use in future large-scale dementia prevention trials.
OBJECTIVES: To identify, characterize and compare the frequency of mildcognitive impairment (MCI) subtypes at baseline in a large, late-life cohort (n = 3063) recruited into a dementia prevention trial. METHOD: A retrospective, data-algorithmic approach was used to classify participants as cognitively normal or MCI with corresponding subtype (e.g. amnestic vs. non-amnestic, single domain vs. multiple domain) based on a comprehensive battery of neuropsychological test scores, with and without Clinical Dementia Rating (CDR) global score included in the algorithm. RESULTS: Overall, 15.7% of cases (n = 480) were classified as MCI. Amnestic MCI was characterized as unilateral memory impairment (i.e. only verbal or only visual memory impaired) or bilateral memory impairment (i.e. both verbal and visual memory impaired). All forms of amnestic MCI were almost twice as frequent as non-amnestic MCI (10.0% vs. 5.7%). Removing the CDR = 0.5 ('questionable dementia') criterion resulted in a near doubling of the overall MCI frequency to 28.1%. CONCLUSION: Combining CDR and cognitive test data to classify participants as MCI resulted in overall MCI and amnestic MCI frequencies consistent with other large community-based studies, most of which relied on the 'gold standard' of individual case review and diagnostic consensus. The present data-driven approach may prove to be an effective alternative for use in future large-scale dementia prevention trials.
Authors: Jennifer J Manly; Diane M Jacobs; Pegah Touradji; Scott A Small; Yaakov Stern Journal: J Int Neuropsychol Soc Date: 2002-03 Impact factor: 2.892
Authors: Annette L Fitzpatrick; Linda P Fried; Jeff Williamson; Patricia Crowley; Delilah Posey; Linly Kwong; Janet Bonk; Roberta Moyer; Joyce Chabot; Lara Kidoguchi; Curt D Furberg; Steven T DeKosky Journal: Contemp Clin Trials Date: 2006-07-04 Impact factor: 2.226
Authors: P Fischer; S Jungwirth; S Zehetmayer; S Weissgram; S Hoenigschnabl; E Gelpi; W Krampla; K H Tragl Journal: Neurology Date: 2007-01-23 Impact factor: 9.910
Authors: Oscar L Lopez; Lewis H Kuller; James T Becker; Corinne Dulberg; Robert A Sweet; H Michael Gach; Steven T Dekosky Journal: Arch Neurol Date: 2007-03
Authors: Oscar L Lopez; William J Jagust; Steven T DeKosky; James T Becker; Annette Fitzpatrick; Corinne Dulberg; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller Journal: Arch Neurol Date: 2003-10
Authors: Oscar L Lopez; Lewis H Kuller; Annette Fitzpatrick; Diane Ives; James T Becker; Norman Beauchamp Journal: Neuroepidemiology Date: 2003 Jan-Feb Impact factor: 3.282
Authors: Kathryn E Callahan; James F Lovato; Michael E Miller; Doug Easterling; Beth Snitz; Jeff D Williamson Journal: J Am Geriatr Soc Date: 2015-08-27 Impact factor: 5.562
Authors: Manja Koch; Simona Costanzo; Annette L Fitzpatrick; Oscar L Lopez; Steven DeKosky; Lewis H Kuller; Julie Price; Rachel H Mackey; Majken K Jensen; Kenneth J Mukamal Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg Journal: JAMA Date: 2008-11-19 Impact factor: 56.272
Authors: Beth E Snitz; Ellen S O'Meara; Michelle C Carlson; Alice M Arnold; Diane G Ives; Stephen R Rapp; Judith Saxton; Oscar L Lopez; Leslie O Dunn; Kaycee M Sink; Steven T DeKosky Journal: JAMA Date: 2009-12-23 Impact factor: 56.272
Authors: Carlos Muñoz-Neira; Oscar L López; Rodrigo Riveros; Javier Núñez-Huasaf; Patricia Flores; Andrea Slachevsky Journal: Dement Geriatr Cogn Disord Date: 2012-07-11 Impact factor: 2.959
Authors: Claire E Adam; Annette L Fitzpatrick; Cindy S Leary; Anjum Hajat; Elizabeth A Phelan; Christina Park; Erin O Semmens Journal: Int J Environ Res Public Health Date: 2021-04-02 Impact factor: 3.390
Authors: Timothy M Hughes; Suzanne Craft; Laura D Baker; Mark A Espeland; Stephen R Rapp; Kaycee M Sink; Alain G Bertoni; Gregory L Burke; Rebecca F Gottesman; Erin D Michos; José A Luchsinger; Annette L Fitzpatrick; Kathleen M Hayden Journal: Alzheimers Dement (Amst) Date: 2017-03-31